SI0885013T1 - - Google Patents

Info

Publication number: SI0885013T1
Authority: SI; Slovenia
Prior art keywords: pox; parapox; inducers; multipotent; attenuated
Prior art date: 1996-04-15

Application number

SI9730186T

Other languages

English (en)

Inventor

Anton Mayr

Original Assignee

Anton Mayr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-15

Filing date

1997-04-14

Publication date

2001-12-31

1997-04-14 Application filed by Anton Mayr filed Critical Anton Mayr

2001-12-31 Publication of SI0885013T1 publication Critical patent/SI0885013T1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Mycology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Control Of El Displays (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SI9730186T 1996-04-15 1997-04-14 SI0885013T1 (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19614810		1996-04-15
PCT/DE1997/000761 WO1997038724A1 (de)	1996-04-15	1997-04-14	Neue indikationen für die verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren als arzneimittel

Publications (1)

Publication Number	Publication Date
SI0885013T1 true SI0885013T1 (zh)	2001-12-31

Family

ID=7791302

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9730186T SI0885013T1 (zh)	1996-04-15	1997-04-14

Country Status (20)

Country	Link
US (1)	US6162600A (zh)
EP (1)	EP0885013B1 (zh)
JP (1)	JP3568208B2 (zh)
KR (1)	KR100302994B1 (zh)
CN (1)	CN1165343C (zh)
AT (1)	ATE203678T1 (zh)
AU (1)	AU706729B2 (zh)
BR (1)	BR9708679A (zh)
CA (1)	CA2251690C (zh)
DE (2)	DE59704194D1 (zh)
DK (1)	DK0885013T3 (zh)
ES (1)	ES2125846T3 (zh)
GR (1)	GR3037049T3 (zh)
HU (1)	HU224308B1 (zh)
NO (1)	NO322176B1 (zh)
NZ (1)	NZ332243A (zh)
PL (1)	PL329353A1 (zh)
PT (1)	PT885013E (zh)
SI (1)	SI0885013T1 (zh)
WO (1)	WO1997038724A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK362003A3 (en) *	2000-07-11	2003-07-01	Bayer Ag	Use of strains of the Parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
NZ523535A (en) *	2000-07-11	2004-12-24	Bayer Ag	Use of strains of the Parapoxvirus ovis against organ fibroses
DE10122233A1 (de) *	2000-07-11	2002-01-24	Bayer Ag	Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
US6844000B2 (en)	2001-12-07	2005-01-18	Bayer Pharmaceuticals Corporation	Use of Parapox B2L protein to treat cancer and modify immune responses
DE602005016552D1 (de) *	2004-07-13	2009-10-22	Aicuris Gmbh & Co Kg	Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids
DE102004045758A1 (de) *	2004-09-21	2006-04-06	Toximed Gmbh	Pharmazeutischer Wirkstoff gegen das HIV-Syndrom
DE102005027956B4 (de) *	2005-06-16	2009-10-22	Mayr, Anton, Prof. Dr. Dr. h.c. mult.	Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3504940C2 (de) *	1984-02-17	1997-11-06	Bayer Ag	Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
US6290962B1 (en) *	1992-11-03	2001-09-18	Oravax, Inc.	Urease-based vaccine and treatment for helicobacter infection
DE4405841C1 (de) *	1994-02-23	1995-01-05	Mayr Anton Prof Dr Med Vet Dr	Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

1997
- 1997-04-14 ES ES97922838T patent/ES2125846T3/es not_active Expired - Lifetime
- 1997-04-14 KR KR1019980708260A patent/KR100302994B1/ko not_active IP Right Cessation
- 1997-04-14 PL PL97329353A patent/PL329353A1/xx unknown
- 1997-04-14 CN CNB971938202A patent/CN1165343C/zh not_active Expired - Fee Related
- 1997-04-14 PT PT97922838T patent/PT885013E/pt unknown
- 1997-04-14 BR BR9708679-7A patent/BR9708679A/pt not_active Application Discontinuation
- 1997-04-14 JP JP53664997A patent/JP3568208B2/ja not_active Expired - Lifetime
- 1997-04-14 AU AU28858/97A patent/AU706729B2/en not_active Ceased
- 1997-04-14 DE DE59704194T patent/DE59704194D1/de not_active Expired - Fee Related
- 1997-04-14 CA CA002251690A patent/CA2251690C/en not_active Expired - Fee Related
- 1997-04-14 AT AT97922838T patent/ATE203678T1/de not_active IP Right Cessation
- 1997-04-14 EP EP97922838A patent/EP0885013B1/de not_active Expired - Lifetime
- 1997-04-14 WO PCT/DE1997/000761 patent/WO1997038724A1/de active IP Right Grant
- 1997-04-14 NZ NZ332243A patent/NZ332243A/xx unknown
- 1997-04-14 DK DK97922838T patent/DK0885013T3/da active
- 1997-04-14 SI SI9730186T patent/SI0885013T1/xx unknown
- 1997-04-14 DE DE19780300T patent/DE19780300D2/de not_active Expired - Lifetime
- 1997-04-14 HU HU9901299A patent/HU224308B1/hu not_active IP Right Cessation
1998
- 1998-10-14 US US09/171,269 patent/US6162600A/en not_active Expired - Fee Related
- 1998-10-14 NO NO19984782A patent/NO322176B1/no unknown
2001
- 2001-10-30 GR GR20010401921T patent/GR3037049T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2125846T3 (es)	2001-12-16
NO984782D0 (no)	1998-10-14
KR20000005479A (ko)	2000-01-25
CN1165343C (zh)	2004-09-08
JP3568208B2 (ja)	2004-09-22
CA2251690A1 (en)	1997-10-23
ES2125846T1 (es)	1999-03-16
CA2251690C (en)	2005-11-08
DE59704194D1 (de)	2001-09-06
PL329353A1 (en)	1999-03-29
NZ332243A (en)	2000-10-27
ATE203678T1 (de)	2001-08-15
HUP9901299A3 (en)	2000-03-28
DE19780300D2 (de)	1999-06-17
PT885013E (pt)	2002-01-30
WO1997038724A1 (de)	1997-10-23
HU224308B1 (hu)	2005-07-28
KR100302994B1 (ko)	2001-11-30
JP2000501114A (ja)	2000-02-02
DK0885013T3 (da)	2001-11-05
NO322176B1 (no)	2006-08-21
NO984782L (no)	1998-12-15
HUP9901299A2 (hu)	1999-07-28
US6162600A (en)	2000-12-19
AU2885897A (en)	1997-11-07
BR9708679A (pt)	2000-01-04
CN1215996A (zh)	1999-05-05
EP0885013A1 (de)	1998-12-23
GR3037049T3 (en)	2002-01-31
EP0885013B1 (de)	2001-08-01
AU706729B2 (en)	1999-06-24

Publication	Publication Date	Title
IL157504A0 (en)	2004-03-28	Oncolytic virus therapy
MY141415A (en)	2010-04-30	Therapeutic combination containing interferon
EP0680525A1 (en)	1995-11-08	FIBERS.
GB2333453A (en)	1999-07-28	Colostrinin and uses thereof
SI0885013T1 (zh)	2001-12-31
IT8619529A0 (it)	1986-02-25	Procedimento per combattare particelle di ferro e per la successiva frammentazione del nastro di ferro compattato, e dispositivo per attuare detto procedimento.
MY113092A (en)	2001-11-30	Cisapride extended release
ZA855224B (en)	1986-03-26	Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
ZA923935B (en)	1993-02-24	New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
DE3478397D1 (en)	1989-07-06	Pyrethroid-containing pharmaceutical compositions
ES2013025A6 (es)	1990-04-16	Un metodo para preparar 24r-escimnol.
JPS6455182A (en)	1989-03-02	Human papilloma virus of type 41, dna thereof and protein coded thereby
DE3469020D1 (en)	1988-03-03	Diarylindane-1,3-diones, their preparation and use
ZA876168B (en)	1989-04-26	Human low fc epsilon-receptor,the isolation,the recombinant preparation and purification thereof
EP0960216A4 (en)	2003-01-08	TREATMENT OF HIV INFECTION BY HINDERING THE INTERACTION OF TOPOISOMERASE HOST WITH HIV GAG AND IT
MD916G2 (ro)	1998-12-31	Unguent pentru tratamentul afecţiunilor dentare
WO1998044913A3 (en)	1999-01-28	Compositions containing mkc-442 in combination with other antiviral agents
Confavreux et al.	1986	Trends in European Multiple Sclerosis Research
SE9403861D0 (sv)	1994-11-09	Novel medicinal use
IT8844210A0 (it)	1988-10-28	Sistema per la riduzione della dispersione, per la conservazione e l'uniforme distribuzione del calore nel pentolame da cucina
UA29639A (uk)	2000-11-15	Протипухлинний засіб
GR950100315A (el)	1997-04-30	Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
UA10683A (uk)	1996-12-25	Засіб для лікувальhих ваhh
RO99844B1 (ro)	1990-09-28	Medicament pentru tratamentul gripei si virozelor respiratorii
ZA79295B (en)	1980-02-27	Catalyst,its preparation and use in the polymerisation of butadiene